Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or
Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
07/2012
07/26/2012WO2012099581A1 Dihydrofuropyrimidine compounds
07/26/2012WO2012099129A1 Compound having anti-cancer activity
07/26/2012WO2012098217A1 Fused dihydrofurans as gpr119 modulators for the treatment of diabetes, obesity and related disorders
07/26/2012WO2012066565A3 Asenapine maleate amorphous and crystalline form and process for preparation thereof
07/26/2012WO2012048202A3 Method of preparation of antiviral compounds and useful intermediates thereof
07/26/2012US20120190865 Process for the Preparation of 1-H-pyrrolidine-2,4-dione Derivatives
07/26/2012US20120190701 Renin inhibitors
07/26/2012US20120190651 Anti-inflammatory compounds
07/26/2012US20120189614 Inhibitors of filovirus entry into host cells
07/26/2012US20120187381 Electron Transporting Compounds
07/26/2012CA2825124A1 Fused dihydrofurans as gpr119 modulators for the treatment of diabetes, obesity and related disorders
07/26/2012CA2823955A1 Benzofuro[3,2-c] pyridines and related analogs as serotonin sub-type 6 (5-ht6) modulators for the treatment of obesity, metabolic syndrome, cognition and schizophrenia
07/25/2012EP2479613A1 Photopolymerizable composition, color filter, method for producing same, solid-state image pickup element, liquid crystal display device, lithographic printing original plate, and novel compound
07/25/2012EP2479175A1 Compounds and methods for treating dyslipidemia
07/25/2012EP1961420B1 Agent for prevention and treatment of acute renal failure
07/25/2012EP1954290B1 Tricyclic compounds useful as inhibitors of kinases
07/25/2012CN102603759A Camptothecin E ring analogues and applications thereof as drugs
07/25/2012CN102603758A Extraction method of camptothecin and 9-hydroxymethyl camptothecin from tender leaves and twigs of Nothapodytes nimmoniana
07/25/2012CN102603757A Method for extracting and separating camptothecin from Nothapodytes pittosporoides (Oliv.) Sleum.
07/25/2012CN102603756A Rhodamine B sulfide compound and preparation method and applications of Rhodamine B sulfide compound
07/25/2012CN102603755A Compound with synergetic effect with fluconazole in resisting drug-resisting fungi
07/25/2012CN102603754A Preparation method and application of quinolone alkaloids of Zanthoxylum nitidum
07/25/2012CN101863893B Asymmetrical complete synthesis of Salinosporamide A and analogs thereof
07/25/2012CN101619065B Isoquinoline compound or salt thereof, medicinal composition, preparation method and application thereof
07/25/2012CN101475573B Anti-influenza medicament Tamiflu intermediate, synthesizing method and use thereof
07/24/2012US8227594 Antiviral nucleosides
07/24/2012US8227501 1,6-dihydro-2H-3-oxa-6-aza-as-indacene compounds
07/19/2012WO2012096832A2 Hdac inhibiting derivatives of camptothecin
07/19/2012US20120184532 Galantamine amino acid and peptide prodrugs and uses thereof
07/19/2012US20120184531 BENZOFURO[3,2-c] PYRIDINES AND RELATED ANALOGS AS SEROTONIN SUB-TYPE 6 (5-HT6) MODULATORS FOR THE TREATMENT OF OBESITY, METABOLIC SYNDROME, COGNITION AND SCHIZOPHRENIA
07/19/2012US20120184525 1,2,3-triazolo [4,3-a] pyridine derivatives and thier use for the treatment of prevention of neurological and psychiatric disorders
07/19/2012US20120184516 sGC Stimulators
07/19/2012US20120183577 Compositions useful as inhibitors of protein kinases
07/18/2012EP2476679A2 Substituted triazoles useful as AXL inhibitors
07/18/2012EP2283022B1 Furo [3, 2-b]pyrr0l-3-0nes as cathepsin s inhibitors
07/18/2012EP1937669B9 Novel benzopyran derivatives as potassium channel openers
07/18/2012CN1732163B Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
07/18/2012CN102596925A Antimicrobial polymers
07/18/2012CN102596172A Injectable formulations containing asenapine and method of treatment using same
07/18/2012CN102584843A Extraction method for high-purity tetrodotoxin
07/18/2012CN102584842A Preparation of substituted indole lactam derivative and application of substituted indole lactam derivative as antimalarial agent
07/18/2012CN102584841A Quinoline coumarin derivate and preparation method and application thereof
07/18/2012CN102584800A Compound containing framework of chiral indolone and angelica lactone and asymmetric synthesis method
07/18/2012CN102584760A Enantiomorphous-kaurene diterpene and derivative and preparation method thereof
07/18/2012CN102079747B Olmesartan medoxomil key intermediate, synthesis method thereof and method for synthesizing olmesartan medoxomil from same
07/18/2012CN102020651B 6-aryl amino pyridone formamide MEK (methyl ethyl ketone) inhibitor
07/18/2012CN101974005B Preparation method of high-content sesquiterpenoids tripterygium alkaloid
07/18/2012CN101974002B Naphthapyran derivative containing sulfonamide groups
07/18/2012CN101863894B Tanshinone II A derivative and preparation method and application thereof
07/18/2012CN101747336B Novel method for synthesizing Repirinast
07/18/2012CN101730702B Crystalline forms of topotecan hydrochloride and processes for making the same
07/18/2012CN101501038B Fused [d]pyridazin-7-ones
07/18/2012CN101460457B Total synthesis of salinosporamide a and analogs thereof
07/18/2012CN101124229B Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders
07/17/2012US8222289 Salinosporamides and methods for use thereof
07/17/2012CA2505874C Ccr1 antagonists for the treatment of i.a. demyelinating inflammatory disease
07/12/2012US20120178941 Processes for making epothilone compounds and analogs
07/12/2012US20120178829 Bi - or tricyclic sterically hindered alkoxyamines and process for their preparation
07/12/2012US20120178779 Fused heterocyclic compound and use thereof
07/12/2012US20120178766 Furopyrimidinedione derivatives as trpai modulators
07/12/2012US20120178748 Heteroaryl compounds and methods of use thereof
07/12/2012US20120178737 Tricyclic Heterocyclic Compounds as Phosphoinositide 3-Kinase Inhibitors
07/12/2012US20120178723 Heteroaryls and uses thereof
07/12/2012US20120176571 Polymerizable composition, color filter, and method of producing the same, solid-state imaging device, and planographic printing plate precursor, and novel compound
07/12/2012US20120175598 Carbazole derivative and organic electroluminescent devices utilizing the same and fabrication method thereof
07/11/2012EP2474544A1 Therapeutic agent for anxiety disorders
07/11/2012EP2474543A1 Therapeutic agent for mood disorders
07/11/2012EP2473495A1 Pharmaceutical compounds
07/11/2012EP2473056A1 Chemical compounds
07/11/2012EP2473048A1 Pyranyl aryl methyl benzoquinazolinone m1 receptor positive allosteric modulators
07/11/2012EP1940401B1 Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators
07/11/2012CN102575155A Novel organic electroluminescent compounds and organic electroluminescent device using the same
07/11/2012CN102574866A Camptothecin derivatives
07/11/2012CN102574865A Spirocyclic derivatives as histone deacetylase inhibitors
07/11/2012CN102574864A Fused aminodihydropyrimidone derivatives
07/11/2012CN102574858A Bicyclic heterocycles and their use as CCR2 receptor antagonists
07/11/2012CN102574836A Aminopyrazole derivative
07/11/2012CN102559510A Halophilic aspergillus sp.F1 and application thereof
07/11/2012CN102558140A Derivatives of 4-piperazin-1-1-yl-4-benzo [b] thiophene suitable for the treatment of cns disorders
07/11/2012CN102558121A Compound for organic optoelectronic device, organic light emitting diode and display device
07/11/2012CN102557982A Certain chemical entities, compositions, and methods
07/11/2012CN102557850A Method for preparing cyclic anhydride with substituent group
07/11/2012CN101353344B Pyrazolyl-substituted heterocycles and their use as phytosanitary products
07/10/2012US8217072 Fermentation product of marine actinomyces strains; antiproliferative agents; anticarcinogenic agents; low molecular weight, high pharmaceutical potency, and selectivity for cancer cells
07/10/2012US8217067 Antiinflammatory agents, antidepressants, analgesics, purinergic receptor antagonists; neurodegenerative diseases, spinal cord injuries; 1-(2,3-dichlorophenyl)-N-[(2-methylphenyl)methyl]-1H-tetraazol-5-amine
07/10/2012US8217053 Camptothecin derivatives with antitumor activity
07/10/2012US8217052 Substituted tetrahydropyran spiro pyrrolidinone and piperidinone, preparation and therapeutic use thereof
07/10/2012CA2564062C Indole derivative having piperidine ring
07/10/2012CA2513463C Gyrase inhibitors and uses thereof
07/05/2012WO2012091730A2 Indole alkaloid compounds as melanogenesis promoters and uses thereof
07/05/2012WO2012090179A2 Isoquinoline derivatives as cannabinoid receptor modulators
07/05/2012WO2012090177A2 Cannabinoid receptor modulators
07/05/2012WO2012011741A9 Novel fusarisetin compounds, and use thereof
07/05/2012US20120172590 Methods for isolating alkaloids from plants
07/05/2012US20120172583 Oligonucleotides and Analogs Labeled with Energy Transfer Dyes
07/05/2012US20120172348 Sterol derivative
07/05/2012US20120172346 Use of nicotinic acetylcholine receptor alpha 7 activators
07/05/2012US20120171245 Inhibitors of influenza viruses replication
07/05/2012US20120171227 Pro-drug complexes and related methods of use
07/05/2012US20120171199 Tricyclic pi3k inhibitor compounds and methods of use
1 ... 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 ... 298